×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

GERD and NERD Treatment Market Trends

ID: MRFR/Pharma/4106-CR
90 Pages
Rahul Gotadki
February 2018

Americas Gerd and Nerd Treatment Market Research Report Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid And Liquid), End User (Hospitals and Clinics, Research Centers, And Others) -Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

GERD and NERD Treatment Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the GERD and NERD Treatment Market

The market for gastroesophageal reflux disorder (GERD) and non-erosive reflux ailment (NERD) treatment is witnessing an upward thrust in incidence globally, driven by factors consisting of changing dietary behavior, obesity, and life-style-associated elements, mainly due to accelerated demand for powerful remedy alternatives. Technological improvements in diagnostic gear, which include esophageal pH monitoring, impedance testing, and endoscopy, are enhancing the accuracy and early detection of GERD and NERD Treatment, leading to personalized treatment strategies and riding market boom. Pharmacological treatment remains the cornerstone of GERD and NERD Treatment control, with proton pump inhibitors (PPIs) and H2 receptor antagonists being the most generally prescribed medications, accounting for a full-size share of the market. Healthcare carriers are more and more adopting a patient-centric technique in GERD and NERD treatment management, tailoring treatment plans to characterize patient needs and possibilities, thereby enhancing market accessibility and growth. The integration of telemedicine platforms and faraway tracking solutions for GERD and NERD Treatment patients, making an allowance for virtual consultations and compliance with care, is enhancing admission to to specialized care and using market expansion. Investments in healthcare infrastructure, including specialized gastroenterology clinics and ambulatory surgical facilities, are improving access to GERD and NERD Treatment remedies and using market growth. Increasing investment in clinical trials and research studies centered on novel treatments for GERD and NERD Treatment, together with reflux inhibitors and mucosal protectants, is riding innovation inside the market and contributing to market growth. Increasing efforts closer to patient schooling and cognizance programs regarding GERD and NERD Treatment, such as their causes, symptoms, and remedy options, are empowering patients to make knowledgeable selections and using market increase. Public health initiatives geared toward elevating consciousness about GERD and NERD treatment prevention, early reputation, and management are reducing sickness burdens and driving market demand for specialized treatment offerings. The globalization of healthcare services is enabling patients to access specialized GERD and NERD treatment alternatives throughout borders due to extended market opposition and riding innovation within the market.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

At what CAGR is the Americas GERD & NERD treatment market projected to grow during the forecast period?

Americas GERD & NERD treatment market is projected to grow at a 7.63% CAGR By 2032

Which region is expected to dominate the GERD & NERD treatment market?

The Americas is expected to dominate the GERD & NERD treatment market.

What are the key factors driving the Americas GERD & NERD treatment market?

Rising incidence of reflux disorder and increasing cases of smoking are key factors driving the GERD & NERD treatment market.

Which drug class segment will dominate the Americas GERD & NERD treatment market?

Proton pump inhibitors will dominate the GERD & NERD treatment market.

What are the end users of the Americas GERD & NERD treatment market?

End users of the GERD & NERD treatment market include research centers, hospitals and clinics, and others.

Market Summary

The Global Americas GERD and NERD Treatment Market is projected to grow significantly from 2.16 USD Billion in 2024 to 5.22 USD Billion by 2035.

Key Market Trends & Highlights

Americas GERD & NERD Treatment Key Trends and Highlights

  • The market is expected to experience a compound annual growth rate (CAGR) of 8.36% from 2025 to 2035. By 2035, the market valuation is anticipated to reach 5.22 USD Billion, indicating robust growth potential. In 2024, the market is valued at 2.16 USD Billion, reflecting the current demand for GERD and NERD treatments. Growing adoption of innovative treatment options due to increasing prevalence of GERD and NERD is a major market driver.

Market Size & Forecast

2024 Market Size 2.16 (USD Billion)
2035 Market Size 5.22 (USD Billion)
CAGR (2025-2035) 8.36%
Largest Regional Market Share in 2024 latin_america)

Major Players

<p>AstraZeneca Plc (U.K), Boston Scientific Corporation (U.S.), Cempra Inc. (U.S.), Eisai Co., Ltd. (Japan), EndoGastric Solutions Inc. (U.S.), EndoStim Inc. (U.S.), GlaxoSmithKline Plc (U.K), Ironwood Pharmaceuticals, Inc. (U.S.), Jeil pharmaceutical Co.Ltd. (South Korea), Johnson &amp; Johnson (U.S.), Mederi Therapeutics Inc. (U.S.), Medigus Ltd. (Israel), Medtronic Inc. (U.S.), Merck &amp; CO., Inc. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceuticals Industries Limited (Israel), Torax Medical (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Carbon Medical technologies (U.S.), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), Sanofi (France)</p>

Market Trends

GERD and NERD Treatment Market Market Drivers

Aging Population

The aging population in the Americas serves as a significant driver for the Global Americas GERD and NERD Treatment Market Industry. As individuals age, the prevalence of GERD and NERD tends to increase due to physiological changes and comorbidities associated with older age. This demographic shift necessitates a greater focus on treatment options tailored to the needs of older adults. With the population aged 65 and older projected to reach 80 million by 2040, the demand for effective GERD and NERD treatments is expected to rise correspondingly, thereby propelling market growth.

Market Growth Projections

The Global Americas GERD and NERD Treatment Market Industry is projected to experience substantial growth over the next decade. With an estimated market value of 2.16 USD Billion in 2024, it is expected to expand to 5.22 USD Billion by 2035, reflecting a CAGR of 8.36% from 2025 to 2035. This growth trajectory indicates a robust response to the increasing prevalence of GERD and NERD, advancements in treatment options, and heightened awareness among patients and healthcare providers. The market dynamics suggest a promising future for stakeholders involved in the development and distribution of GERD and NERD treatments.

Increased Awareness and Diagnosis

Growing awareness regarding GERD and NERD symptoms among the general population and healthcare providers is a crucial driver for the Global Americas GERD and NERD Treatment Market Industry. Enhanced educational initiatives and campaigns have led to improved diagnosis rates, allowing for timely intervention. As more individuals seek medical advice for reflux-related symptoms, the demand for diagnostic tools and treatment options is likely to rise. This trend is reflected in the projected compound annual growth rate (CAGR) of 8.36% from 2025 to 2035, indicating a robust market response to increased awareness and proactive healthcare measures.

Rising Prevalence of GERD and NERD

The increasing prevalence of gastroesophageal reflux disease (GERD) and non-erosive reflux disease (NERD) is a primary driver for the Global Americas GERD and NERD Treatment Market Industry. Recent estimates indicate that approximately 20% of the American population experiences GERD symptoms, contributing to a growing demand for effective treatment options. This trend is expected to continue, with the market projected to reach 2.16 USD Billion in 2024. The rising incidence of obesity and lifestyle factors, such as diet and stress, further exacerbate the condition, leading to a heightened focus on therapeutic interventions.

Advancements in Treatment Modalities

Innovations in treatment modalities significantly influence the Global Americas GERD and NERD Treatment Market Industry. The introduction of novel pharmacological agents, including proton pump inhibitors and H2 receptor antagonists, has transformed the management of GERD and NERD. Additionally, minimally invasive surgical techniques, such as fundoplication, have gained traction, offering patients effective alternatives to traditional surgery. As these advancements continue to evolve, they are likely to enhance patient outcomes and satisfaction, driving market growth. The anticipated expansion of the market to 5.22 USD Billion by 2035 underscores the importance of ongoing research and development in this field.

Lifestyle Changes and Dietary Habits

Shifts in lifestyle and dietary habits contribute to the rising incidence of GERD and NERD, thus impacting the Global Americas GERD and NERD Treatment Market Industry. The consumption of high-fat, spicy foods, and the prevalence of sedentary lifestyles have been linked to increased reflux symptoms. As awareness of these correlations grows, there is a potential for increased demand for therapeutic interventions. This trend may be further amplified by public health initiatives aimed at promoting healthier lifestyles, which could lead to a more proactive approach to managing GERD and NERD.

Market Segment Insights

Get more detailed insights about Americas GERD & NERD Treatment Market Research Report- Forecast till 2035

Regional Insights

Key Companies in the GERD and NERD Treatment Market market include

Industry Developments

Future Outlook

GERD and NERD Treatment Market Future Outlook

<p>The Americas GERD &amp; NERD Treatment Market is projected to grow at an 8.36% CAGR from 2024 to 2035, driven by increasing prevalence and advancements in treatment options.</p>

New opportunities lie in:

  • <p>Develop innovative drug delivery systems to enhance patient compliance and treatment efficacy. Invest in telehealth solutions for remote monitoring and management of GERD &amp; NERD patients. Explore partnerships with technology firms to integrate AI in diagnostic processes.</p>

<p>By 2035, the market is expected to demonstrate robust growth, reflecting evolving treatment paradigms and patient needs.</p>

Market Segmentation

Report Scope

FAQs

At what CAGR is the Americas GERD & NERD treatment market projected to grow during the forecast period?

Americas GERD &amp; NERD treatment market is projected to grow at a 7.63% CAGR By 2032

Which region is expected to dominate the GERD & NERD treatment market?

The Americas is expected to dominate the GERD &amp; NERD treatment market.

What are the key factors driving the Americas GERD & NERD treatment market?

Rising incidence of reflux disorder and increasing cases of smoking are key factors driving the GERD &amp; NERD treatment market.

Which drug class segment will dominate the Americas GERD & NERD treatment market?

Proton pump inhibitors will dominate the GERD &amp; NERD treatment market.

What are the end users of the Americas GERD & NERD treatment market?

End users of the GERD &amp; NERD treatment market include research centers, hospitals and clinics, and others.

  1. Report Prologue
  2. Market Introduction
    1. Definition 14
    2. Scope of the Study 14
      1. Research Objective 14
      2. Assumptions 14
      3. Limitations 14
  3. Research Methodology
  4. Primary Research Methodology 17
  5. Data Points Received from the Doctors/ Gastrologist: 17
  6. Data points received from the Manufacturer/ Pharmaceutical Companies: 18
  7. Data points received from Hospitals, Clinics: 18
  8. Secondary Research Methodology 20
  9. Market Share Analysis 22
  10. Trade Analysis 22
  11. Market Pricing Approach 22
  12. Market Dynamics
    1. Introduction 23
    2. Drivers 24
      1. Increasing cases of smoking to boost the market growth (Impact weightage- 20%) 24
      2. Rising cases of reflux disorder during pregnancy (impact weightage- 15%) 25
      3. Changing lifestyle and irregular dietary habits (Impact weightage- 15%) 26
      4. Increasing incidence of acid reflux disorder (heartburn) will boost the American GERD& NERD treatment market (Impact weightage- 25%) 27
      5. Growing geriatric population (impact weightage- 15%) 28
      6. Increasing demands for endoscopy biopsy procedures for early diagnosis (Impact weightage- 10%) 29
    3. Restraints 30
      1. Loss of patent exclusivity and lack of pipeline drugs (impact weightage- 55%) 30
      2. High cost of the gastroscopes (weightage impact- 45%) 31
    4. Opportunity 32
      1. Development of new drugs 32
    5. Mega Trends 32
    6. Macroeconomic Indicators 32
    7. Technology Trends & Assessment 33
  13. Market Factor Analysis
    1. Porters Five forces Model 34
      1. Bargaining Power of Suppliers 35
      2. Bargaining Power of Buyers 35
      3. Threat of New Entrants 35
      4. Threat of Substitutes 35
      5. Intensity of Rivalry 36
    2. Value Chain Analysis 36
      1. R&D 37
      2. Manufacturing 37
      3. Distribution & Sales 37
      4. Post-Sales Monitoring 37
    3. Demand & Supply: Gap Analysis 38
    4. Pricing Analysis 38
    5. Investment Opportunity Analysis 38
  14. Americas GERD & NERD Treatment Market, by Drug class
    1. Introduction 39
    2. Antacids (Acid Neutralizers) 40
    3. Proton Pump Inhibitors 41
      1. Esomeprazole 41
      2. Omeprazole 42
      3. Pantoprazole 42
      4. Lansoprazole 43
      5. Dexlansoprazole 43
      6. Rabeprazole 43
    4. H2 receptor blocker 44
      1. Ranitidine 44
      2. Famotidine 45
      3. Cimetidine 45
      4. Nizatidine 46
    5. Pro kinetic agents 46
      1. Domperidone 46
      2. Metoclopramide 47
      3. Itopride 47
      4. Prucalopride 47
      5. Cisapride 48
      6. Benzamide 48
      7. Mosapride 48
      8. Erythromycin 49
    6. Antidepressants 49
    7. Calcium Channel Blockers 50
  15. Americas GERD & NERD Treatment Market, by Dosage Form
    1. Introduction 51
    2. Solid 52
    3. Liquid 52
  16. Americas GERD & NERD Treatment Market, by End User
    1. Introduction 53
    2. Hospitals & Clinics 54
    3. Research Centers 54
  17. Americas GERD & NERD Treatment Market, by Region
    1. Introduction 55
    2. North America 57
      1. U.S. 60
      2. Canada 63
    3. South America 66
  18. Competitive Landscape
    1. Introduction 69
    2. Company Share Analysis 69
  19. Company Profiles
    1. AstraZeneca 70
      1. Company Overview 70
      2. Financials 70
      3. Products 70
      4. Strategy 70
      5. Key Developments 70
    2. Addex Pharmaceuticals 71
      1. Company Overview 71
      2. Financials 71
      3. Products 71
      4. Strategy 71
      5. Key Developments 71
    3. Takeda Pharmaceutical 72
      1. Company Overview 72
      2. Financials 72
      3. Products 72
      4. Strategy 72
      5. Key Developments 72
    4. Eisai Co., Ltd 73
      1. Company Overview 73
      2. Financials 73
      3. Products 73
      4. Strategy 73
      5. Key Developments 73
    5. Medigus Ltd 74
      1. Company Overview 74
      2. Financials 74
      3. Products 74
      4. Strategy 74
      5. Key Developments 74
    6. RaQualia Pharma Inc 75
      1. Company Overview 75
      2. Financials 75
      3. Products 75
      4. Strategy 75
      5. Key Developments 75
    7. Torax Medical 76
      1. Company Overview 76
      2. Financials 76
      3. Products 76
      4. Strategy 76
      5. Key Developments 76
    8. Carbon Medical technologies 77
      1. Company Overview 77
      2. Financials 77
      3. Products 77
      4. Strategy 77
      5. Key Developments 77
    9. Endogastric Solutions 78
      1. Company Overview 78
      2. Financials 78
      3. Products 78
      4. Strategy 78
      5. Key Developments 78
    10. Medtronic 79
      1. Company Overview 79
      2. Financials 79
      3. Products 79
      4. Strategy 79
      5. Key Developments 79
    11. Pfizer 80
      1. Company Overview 80
      2. Financials 80
      3. Products 80
      4. Strategy 80
      5. Key Developments 80
    12. Novartis AG. 81
      1. Company Overview 81
      2. Financials 81
      3. Products 81
      4. Strategy 81
      5. Key Developments 81
    13. GlaxoSmithKline plc 82
      1. Company Overview 82
      2. Financials 82
      3. Products 82
      4. Strategy 82
      5. Key Developments 82
    14. Valeant Pharmaceuticals 83
      1. Company Overview 83
      2. Financials 83
      3. Products 83
      4. Strategy 83
      5. Key Developments 83
    15. Ironwood Pharmaceuticals, Inc. 84
      1. Company Overview 84
      2. Financials 84
      3. Products 84
      4. Strategy 84
      5. Key Developments 84
  20. Appendix
    1. Discussion Blue Print 85
  21. MRFR Conclusion
    1. Key Findings 87
      1. From CEO’s View Point 87
      2. Unmet Needs 87
    2. Key companies to watch 87
  22. List of Tables
  23. PRIMARY INTERVIEWS 19
  24. AMERICAS GERD & NERD TREATMENT MARKET, BY ANTACIDS (ACID NEUTRALIZERS), 2023 & 2030 (USD MILLION) 40
  25. AMERICAS GERD & NERD TREATMENT MARKET, BY PROTON PUMP INHIBITORS, 2023 TO 2030 (USD MILLION) 41
  26. AMERICAS GERD & NERD TREATMENT MARKET, BY ESOMEPRAZOLE, 2023 TO 2030 (USD MILLION) 41
  27. AMERICAS GERD & NERD TREATMENT MARKET, BY OMEPRAZOLE, 2023 TO 2030 (USD MILLION) 42
  28. AMERICAS GERD & NERD TREATMENT MARKET, BY PANTOPRAZOLE, 2023 TO 2030 (USD MILLION) 42
  29. AMERICAS GERD & NERD TREATMENT MARKET, BY LANSOPRAZOLE, 2023 TO 2030 (USD MILLION) 43
  30. AMERICAS GERD & NERD TREATMENT MARKET, BY DEXLANSOPRAZOLE, 2023 TO 2030 (USD MILLION) 43
  31. AMERICAS GERD & NERD TREATMENT MARKET, BY RABEPRAZOLE, 2023 TO 2030 (USD MILLION) 43
  32. AMERICAS GERD & NERD TREATMENT MARKET, BY H2 RECEPTOR BLOCKER, 2023 TO 2030 (USD MILLION) 44
  33. AMERICAS GERD & NERD TREATMENT MARKET, BY RANITIDINE, 2023 TO 2030 (USD MILLION) 44
  34. AMERICAS GERD & NERD TREATMENT MARKET, BY FAMOTIDINE, 2023 TO 2030 (USD MILLION) 45
  35. AMERICAS GERD& NERD TREATMENT MARKET, BY CIMETIDINE, 2023 TO 2030 (USD MILLION) 45
  36. AMERICAS GERD & NERD TREATMENT MARKET, BY NIZATIDINE, 2023 TO 2030 (USD MILLION) 46
  37. AMERICAS GERD & NERD TREATMENT MARKET, BY DOMPERIDONE, 2023 TO 2030 (USD MILLION) 46
  38. AMERICAS GERD & NERD TREATMENT MARKET, BY METOCLOPRAMIDE, 2023 TO 2030 (USD MILLION) 47
  39. AMERICAS GERD & NERD TREATMENT MARKET, BY ITOPRIDE, 2023 TO 2030 (USD MILLION) 47
  40. AMERICAS GERD & NERD TREATMENT MARKET, BY PRUCALOPRIDE, 2023 TO 2030 (USD MILLION) 47
  41. AMERICAS GERD & NERD TREATMENT MARKET, BY CISAPRIDE, 2023 TO 2030 (USD MILLION) 48
  42. AMERICAS GERD & NERD TREATMENT MARKET, BY BENZAMIDE, 2023 TO 2030 (USD MILLION) 48
  43. AMERICAS GERD & NERD TREATMENT MARKET, BY MOSAPRIDE, 2023 TO 2030 (USD MILLION) 48
  44. AMERICAS GERD & NERD TREATMENT MARKET, BY ERYTHROMYCIN, 2023 TO 2030 (USD MILLION) 49
  45. AMERICAS GERD & NERD TREATMENT MARKET, BY ANTIDEPRESSANTS, 2023 TO 2030 (USD MILLION) 49
  46. AMERICAS GERD & NERD TREATMENT MARKET, BY CALCIUM CHANNEL BLOCKERS, 2023 TO 2030 (USD MILLION) 50
  47. AMERICAS GERD & NERD TREATMENT MARKET, BY SOLID, 2023 TO 2030 (USD MILLION) 52
  48. AMERICAS GERD & NERD TREATMENT MARKET, BY LIQUID, 2023 TO 2030 (USD MILLION) 52
  49. AMERICAS GERD & NERD TREATMENT MARKET, BY HOSPITALS & CLINICS, 2023 TO 2030 (USD MILLION) 54
  50. AMERICAS GERD & NERD TREATMENT MARKET, BY RESEARCH CENTERS, 2023 TO 2030 (USD MILLION) 54
  51. AMERICAS GERD & NERD TREATMENT MARKET, BY REGION, 2023 TO 2030 (USD MILLION) 56
  52. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 57
  53. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 57
  54. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 58
  55. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 58
  56. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2023-2030 (USD MILLION) 59
  57. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY END USER, 2023-2030 (USD MILLION) 59
  58. U.S. GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 60
  59. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 60
  60. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 61
  61. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 61
  62. U.S. GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2023-2030 (USD MILLION) 62
  63. U.S. GERD & NERD TREATMENT MARKET, BY END USER, 2023-2030 (USD MILLION) 62
  64. CANADA GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 63
  65. CANADA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 63
  66. CANADA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 64
  67. CANADA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 64
  68. CANADA GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2023-2030 (USD MILLION) 65
  69. CANADA GERD & NERD TREATMENT MARKET, BY END USER, 2023-2030 (USD MILLION) 65
  70. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 66
  71. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 66
  72. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 67
  73. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 67
  74. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2023-2030 (USD MILLION) 68
  75. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY END USER, 2023-2030 (USD MILLION) 68
  76. List of Figures
  77. AMERICAS GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023 & 2030 (USD MILLION) 12
  78. AMERICAS GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2023 & 2030 (USD MILLION) 12
  79. AMERICAS GERD & NERD TREATMENT MARKET, BY END USER, 2023 & 2030 (USD MILLION) 13
  80. MARKET STRUCTURE 15
  81. RESEARCH METHODOLOGY 16
  82. DATA TRIANGULATION PRIMARY 19
  83. DATA TRIANGULATION METHOD 21
  84. PORTER’S FIVE FORCES MODEL 34
  85. AMERICAS GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023 & 2030 (USD MILLION) 39
  86. AMERICAS GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2023 & 2030 (USD MILLION) 51
  87. AMERICAS GERD & NERD TREATMENT MARKET, BY END USER, 2023 & 2030 (USD MILLION) 53
  88. AMERICAS GERD & NERD TREATMENT MARKET, BY END USER, 2023 & 2030 (USD MILLION) 56

Americas GERD & NERD Treatment Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓